Angiosarcoma arising in the non-operated, sclerosing breast after primary irradiation, surviving 6 years post-resection: A case report and review of the Japanese literature  by Ito, Takaaki et al.
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INTRODUCTION:  Angiosarcoma  consists  only  0.04%  of  all breast  malignancies  and has  a  poor  progno-
sis.  This  is the  ﬁrst  reported  case of  an  angiosarcoma  arising  in  the  non-operated  breast  after  primary
irradiation  for  occult  breast  cancer.  The  patient  underwent  mastectomy,  surviving  disease  free for  6 years.
PRESENTATION  OF  CASE:  A 73-year-old  woman  with  a  past  history  of  irradiation  of the  non-operated
left  breast  complained  of  skin  thickening  and  crust  formation  on the  left  nipple  8  years  post-irradiation.
Considering  the  clinical  history  and  radiological  studies,  recurrent  cancer  was  suspected  and  biopsy  was
performed.  However,  no  proof  of malignancy  was obtained.  As  clinical  symptoms  continued  to  advance,
informed  consent  was  obtained  and  mastectomy  was  performed.  Histological  examination  of  the  surgical
specimen  revealed  angiosarcoma.
DISCUSSION:  In this  case,  angiosarcoma  occurred  after  radiation  on a non-operated  breast.  Preoperative
diagnosis  was  not  achieved  even  with  two cytology  specimen  and  one  biopsy.  Each  showed  only  ﬁbrosis
and  inﬂammatory  changes.  The  background  breast  tissue  inﬂammation  should  have  been  caused  by
radiation.  Marked  ﬁbrosis  and the  rather  small  number  of  sarcoma  cells  in the  breast  tumor  in  this  case
may be why  bioptic  diagnosis  was  difﬁcult.  Kaplan-Meier  analysis  of  60 Japanese  breast  angiosarcoma
patients  showed  signiﬁcantly  better  prognosis  in  patients  with  a tumor  2 cm or smaller.
CONCLUSION:  Angiosarcoma  may  occur  in the  non-operated  breast,  post  irradiation.  The  potential  dif-
ﬁculties  of  diagnosing  angiosarcoma  against  background  ﬁbrosis  should  be kept in mind.  Initial  radical
surgery  currently  represents  the  only  effective  treatment  for improving  survival  in these  patients.
© 2016  The  Author(s).  Published  by Elsevier  Ltd on behalf  of  IJS Publishing  Group  Ltd.  This  is  an  open
he CCaccess  article  under  t
. Introduction
Angiosarcoma represents less than 1% of soft-tissue sarcomas
1]. Angiosarcoma of the breast, which represents 0.04% of breast
alignancies, can be divided into primary and secondary angiosar-
oma. Factors that predispose individuals toward secondary
ngiosarcoma include radiotherapy, Stewart-Treves syndrome and
hronic lymphedema [2]. Radiation-induced angiosarcoma is being
eported with increasing frequency. Most cases occur in the set-
Abbreviation: FNAC, ﬁne needle aspiration cytology.
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210-2612/© 2016 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
ting of breast-conserving therapy and subsequent radiotherapy [1].
However, there has been no report about angiosarcoma after irra-
diation on a non-operated breast. Also, despite the generally poor
prognosis of angiosarcoma, our case is disease free 6 years post-
operation.
2. Case report
A 73-year-old woman received ﬁne needle aspiration cytol-
ogy (FNAC) for a swelling left axillary lymph node in November
2001. FNAC showed metastatic carcinoma, and axillary lymph
node dissection was performed. As FNAC revealed lymph node
metastasis, sentinel lymph node biopsy was  unnecessary. The diag-
nosis was comedo carcinoma, estrogen and progesterone receptor
negative, and HER2/neu positive. As the primary disease could
not be identiﬁed on radiological examination, occult breast can-
cer was suspected. Postoperatively, she received 3 courses of
cyclophosphamide, epirubicin and 5-ﬂuorouracil, with subsequent
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Mammography. Mediolateral oblique view revealing skin thickening and distortion around the left nipple (arrow). No tumor or calciﬁcation is apparent.
Fig. 2. Magnetic resonance imaging.
A mass with irregular margins. The mass shows heterogeneous hyperintensity on T2-weighted imaging (A), and hypointensity on T1-weighted imaging (B). Contrast-enhanced
T1-weighted imaging shows enhancement of the mass (C).
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Table 1
Clinicopathologic features of 60 Japanese angiosarcoma cases.
Author Year Age of patient at diagnosis Tumor diameter at diagnosis Operative method Site of recurrence Observation period (Months) Outcome
Sakaguchi 1932 27 16 Mastectomy Surgical site, Contralateral
breast, Bilateral ovary
37 Dead
Ishizuka/Watanabe 1965/1974 52 12 Mastectomy + Axillary
dissection
Lung, Bone 51 Dead
Tanaka/Hamazaki 1971/1978 22 13 Mastectomy + Axillary
dissection
Surgical site, Lung, Liver 37 Dead
Watanabe 1973 51 3 Mastectomy Stomach, Lung, Pharynx,
Uterine Cervix, Chest wall
14 Dead
Kunii  1982 42 1 Mastectomy + Axillary
dissection
None 11 Alive
Koike  1982 21 7.2 Mastectomy + Axillary
dissection
Surgical site, Chest wall 24 Dead
Shikama 1986 28 18 Mastectomy Contralateral breast, Bone,
Lung, Bilateral ovary
15 Dead
Sakuma  1987 19 22 Mastectomy Surgical site, Contralateral
breast, Chest wall
30 Alive
Yamashina 1987 71 16 Mastectomy + Axillary
dissection
Lung 6 Alive
Tamura 1987 24 9 Mastectomy + Axillary
dissection
None 26 Alive
Kawazu 1988 42 7.3 Mastectomy + Axillary
dissection
Skin 12 Alive
Matoba/Shou 1988 25 16 Mastectomy + Axillary
dissection
Surgical site, Skin, Bilateral
ovary
27 Alive
Iseki  1989 60 1.3 Mastectomy + Axillary
dissection
None 8 Alive
Yokoyama 1990 33 9 Mastectomy + Axillary
dissection
Surgical site, Skin 21 Alive
Ishikawa 1990 26 20 Mastectomy + Axillary
dissection
Lung, Skin 5 Dead
Nagahara 1993 19 8 Mastectomy + Axillary
dissection
Lung, Bone, Liver, Skin 10 Dead
Okanobu 1994 34 1.3 Mastectomy + Axillary
dissection
None 18 Alive
Hayashi  1994 52 9 Mastectomy + Axillary
dissection
Lung 2.5 Dead
Hakata  1995 43 1 Mastectomy + Axillary
dissection
Skin 15 Alive
Nakano  1995 82 2 Mastectomy Lung, Bone, Liver, Skin 3 Dead
Ishizawa 1995 38 4 Lumpectomy Residual Breast, Liver 39 Dead
Tachibana 1996 24 10 Mastectomy + Axillary
dissection
None 10 Alive
Nagasawa 1997 64 2 Mastectomy None 10 Alive
Murakawa 1997 46 1.7 Mastectomy None 60 Alive
Michigami 1997 24 10 Lumpectomy Surgical site, Skin,
Contralateral breast
12 Alive
Kagawa 1997 35 5.5 Lumpectomy Surgical site, Skin, Chest wall,
Lung, Mediastinum, Digestive
tract, Thyroid, Kidney, Adrenal
gland, Ovary, Gall bladder,
Spleen, Bone
6 Dead
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Takanashi 1997 32 10 Mastectomy + Axillary
dissection
Head skin, Ovary, Lung, Liver 8 Dead
Takanashi 1997 25 15 Mastectomy + Axillary
dissection
Ovary, Bone, Liver, Pelvis 34 Dead
Shichinohe 1998 34 0.7 Partial mastectomy + Axillary
dissectionn
None 60 Alive
Kiyono  T 1998 64 26 Mastectomy None 84 Alive
Yamamoto 1998 24 6 Mastectomy Ipsilateral breast, Lung, Liver,
Bone
29 Dead
Tanaka  1999 26 8 Mastectomy + Axillary
dissection
None 12 Alive
Yamada 1999 42 6 Mastectomy + Axillary
dissection
Contralateral breast, Lung,
Liver, Adrenal gland, Bone
15 Dead
Yoshida 2000 41 1.5 Partial mastectomy + Axillary
dissectionn
None 60 Alive
Abe  2000 79 2 Mastectomy Subcutaneous fat of ipsilateral
breast
6 Alive
Ueki  2000 19 1.5 Mastectomy None 30 Alive
Tsumagari K 2000 52 6 Mastectomy + Axillary
dissection
None 9 Alive
Tsumagari K 2000 26 11 Mastectomy + Axillary
dissection
None 18 Alive
Tsumagari K 2000 19 9 Mastectomy + Axillary
dissection
Bone, Liver, Lung, Brain,
Surgical site, Nasal cavity
27 Dead
Kitamura 2001 46 Hand ﬁst size Mastectomy Skin, Liver, Lung 24 Dead
Fujisawa 2003 65 5 Mastectomy Lung, Skin 16 Alive
Nishiyama 2003 18 14 Mastectomy Surgical site, Lung, Liver 9 Dead
Nakayama 2004 40 3 Mastectomy Contralateral breast 51 Alive
Nakata  2004 51 8 Mastectomy + Axillary
dissection
None 16 Alive
Yoneyama 2005 32 5.5 Mastectomy + Axillary
dissection
None 72 Alive
Sadashima 2007 60 2 Mastectomy None 12 Alive
Ueda  S 2008 28 7 Mastectomy Bone 6 Alive
Yoshida C 2008 38 9 Mastectomy None 2 Alive
Ueda  S 2008 44 4 Mastectomy Bilateral breast, Bilateral ovary,
Bone, Lung, Liver
41 Dead
Sakamoto M 2009 32 8 Mastectomy None 4 Alive
Takenaka M 2009 87 11 Mastectomy Lung 2 Dead
Miyasaka M 2010 59 12 Mastectomy None 17 Alive
Komatsu M 2010 54 5.5 Mastectomy None 2 Alive
Oda  T 2011 27 5 Mastectomy + Tissue expander Ovary, Bone, Liver, Pelvis 3 Alive
Satou  F 2011 61 10 Partial mastectomy + sentinel
lymph node biopsy
Ovary, Bone, Liver, Pelvis 14 Alive
Hosono Y 2011 47 3.2 Mastectomy + Sentinel lymph
node biopsy
Lung, Liver 29 Dead
Hoskimoto N 2012 27 7 Mastectomy Skin 40 Alive
Okaminami Y 2013 33 5 Mastectomy None 42 Alive
Mizumoto S 2014 78 16 Mastectomy + lymph node
sampling
Rt knee, pleura 13 Dead
Our  case 2015 73 3.5 Mastectomy None 60 Alive
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( ion and skin thickening at the areola (arrows). (B) Cross-section of the specimen (vertical
a eath the nipple.
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Fig. 4. Pathology (microscopy).
Microscopic examination of the surgically resected specimen, revealing oval-shapedig. 3. Pathology (gross).
A) The resected specimen, showing an irregular mass accompanied by crust format
rrow  in A). A brownish irregular mass leading into the skin thickening is seen ben
rradiation (50 Gy) to the left breast. We  have also proposed the
hoice of mastectomy, which the patient refused.
In November 2007, ultrasonographic study showed a hypoe-
hoic area in the left breast. Core needle biopsy revealed
nﬂammatory pseudotumor.
Then, in May  2009, she complained of skin-thickening and
rust formation at the left areola. Mammography revealed
kin-thickening and distortion around the left nipple (Fig. 1). Ultra-
onography showed the hypoechoic area recognized in 2007, with
hickening of the overlying skin on the left nipple. Magnetic res-
nance imaging showed a 3.5 cm mass with irregular margins.
t was heterogeneous and hyperintense on T2-weighted imaging,
ypointense on T1-weighted imaging, and gradually enhanced in
 dynamic study (Fig. 2). Marked enhancement was suggestive of
alignancy, but the gradual enhancement was inconsistent with
ommon breast malignancies. Computed tomography showed skin
hickening and an enhanced area with obscure borders beneath the
eft nipple.
From radiological studies, primary breast cancer, recurrence or
arcoma was suspected. Given the clinical history, recurrence was
trongly suspected. Even though FNAC, Vacuum-assisted biopsy
VACORA®; Bard Biopsy Systems, Tempe, AZ) and skin biopsy spec-
mens were performed, diagnosis of malignant tumor was  not
btained.
However, as skin thickening of the peri-nipple area continued
o advance, clinically malignant tumor was suspected. After careful
iscussion with the patient, informed consent was  obtained and
imple mastectomy was performed in June 2009.
Macroscopically, an irregular shaped mass with crust forma-
ion and skin-thickening was observed in the areola region of the
esected specimen (Fig. 3).
Histopathological examination revealed oval-shaped neoplastic
tromal cells arranged in sinusoidal pattern, accompanying mitoses
nd background ﬁbrosis (Fig. 4). The tumor was negative for estro-
en, progesterone and HER2/neu receptors. Immunohistochemical
taining yielded positive for CD34, vimentin and factor VIII, and
egative for cytokeratin. The histological diagnosis was  angiosar-
oma of the breast.
Paclitaxel was administered as postoperative chemotherapy.
ow, 6 years post-operation (February 2016), the patient is clin-
cally free of disease.. Discussion
Breast angiosarcoma is rare, and primary angiosarcoma of the
reast makes up only 0.00005% of all breast malignancies [2]. Thecells arranged in the form of endovascular cells, accompanied by mitosis and back-
ground ﬁbrosis.
frequency of angiosarcoma increases to 0.16% after radiotherapy.
This represents an approximately 3200-fold increase in relative risk
for patients who  undergo breast-conserving surgery [3].
Angiosarcoma should thus be considered in any post-radiation
patient with skin thickening or mammographic density [4].
Angiosarcoma tend to present 5–6 years, after breast-
conserving therapy and subsequent radiotherapy [5].
According to the recent literature, (1) axillary lymph node detec-
tion (ALND) + radiotherapy and (2) ALND + mastectomy are both the
treatment of choice in occult breast carcinoma. (1) and (2) have the
same survival outcomes [6,7]. We  would like to point out that one
has to keep in mind the possibility of the development of angiosar-
coma in the cases that received treatment choice (1).
The unique feature about this case is the cause of the angiosar-
coma. In usual case reports, the patients receive both breast
conservation surgery and radiotherapy. In the diagnostic imag-
ing of angiosarcoma in these cases, it is hard to tell whether the
back ground ﬁbrosis was  caused by surgery and radiotherapy, or
the tumor itself. However, in our case, we  had performed only
radiotherapy, and it is reasonable to consider that angiosarcoma
occurred from a radiation scar. This case is valuable in the respect
that from its clinical course, rather intense ﬁbrosis occurred in the
breast caused by irradiation, and the development of angiosarcoma
 –  O
f Surg
f
t
i
t
m
a
s
t
ﬁ
d
n
b
c
a
b
c
m
s
i
a
c
r
w
i
s
5
c
a
A
t
w
t
A
w
3
c
d
C
F
[
O
T
p
cCASE  REPORT
T. Ito et al. / International Journal o
rom the sclerosing breast was conﬁrmed by the interpretation of
he resected specimen.
In the reported cases, preoperative diagnosis of angiosarcoma
s usually made by needle biopsy specimen [1,8]. However, due to
he variety of pathological features, some angiosarcoma cases are
isdiagnosed as hemangioma [9].
In our case, preoperative diagnosis of angiosarcoma was not
chieved even with two cytology specimen and one biopsy. Each
howed only ﬁbrosis and inﬂammatory changes.
Wijnmaalen et al. reported background breast tissue inﬂamma-
ion caused by radiation in 8 cases of angiosarcoma, also ﬁnding
brosis in 7 (88%) [10].
When angiosarcoma occurs against such a background, correct
iagnosis may  be difﬁcult. Marked ﬁbrosis and the rather small
umber of sarcoma cells in the breast tumor in the present case may
e why bioptic diagnosis was difﬁcult. In this case, the tumor was
onsidered to be high grade from its clinically aggressive nature,
nd as histology revealed abundant mitosis.
The potential difﬁculties of diagnosing angiosarcoma against
ackground ﬁbrosis should be kept in mind, particularly in tumors
onsisted of rather small number of angiosarcoma cells, and
arked ﬁbrosis caused by radiation.
Concerning treatment, initial radical surgery currently repre-
ents the only effective treatment for achieving long-term survival
n angiosarcoma patients [8].
Other reports have indicated that hyperfractionated radiother-
py of secondary high-grade angiosarcoma has resulted in reduced
ell repopulation [11].
Adjuvant chemotherapy, paclitaxel for example, may  also
educe the local recurrence rate [1]. In the present case, paclitaxel
as performed.
Angiosarcoma has a poor prognosis, and median overall survival
s 22–37 months [3]. Vorburger et al. reported that tumors 5 cm or
maller in diameter have a better prognosis than those larger than
 cm [12].
The clinicopathologic features of 60 reported Japanese angiosar-
oma cases were reviewed. The relation between tumor diameter
nd prognosis was analyzed by Kaplan-Meier method (SPSS®; IBM,
rmonk, NY).
The mean observation period was 22.7 months (2–84 months),
he mean age was 41.5 years old (18–87). Mean tumor diameter
as 7.8 cm (0.7–26 cm). The operations performed were mastec-
omy in 54 cases (90.0%), partial mastectomy in 6 cases (10.0%).
xillary dissection was performed in 28 cases (46.7%), but there
ere no lymph node metastasis. Distant metastasis was found in
2 (53.3%) cases (Table 1). Kaplan-Meier analysis showed signiﬁ-
antly better prognosis in patients with a tumor 2 cm or smaller in
iameter (p = 0.0457) [13].
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